In fact, a few years ago, the National Institute on Aging (NIA) and Alzheimer’s Association (AA) defined AD diagnostic criteria solely based on the presence or absence of Aβ and tau pathologies as well as neurodegeneration (A+T+N+) [20]. The gene discussed is MAPT; the disease is Alzheimer disease.